Acromegaly
📧 Sign up to get email alerts when something new happens for Acromegaly.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-11-17Clinical Trial Update: Short and Long Term Efficacy of Combined Cabergoline and Octreotide Treatment in Acromegalic Patients
This clinical trial update reports the completed evaluation of short- and long-term efficacy for combining cabergoline with octreotide in pa…
-
CLINICAL_TRIALS trial_result · 2009-10-12Clinical Trial Update: Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas [Phase 2]
This document provides an update on a Phase 2 trial evaluating preoperative lanreotide for patients with acromegaly and macroadenomas.
-
CLINICAL_TRIALS trial_result · 2009-09-02Clinical Trial Update: Cardiac Function and Morphology Evaluated by Magnetic Resonance Imaging in Growth Hormone Deficiency and Acromegaly
A completed clinical trial evaluating cardiac structure and function by MRI in individuals with growth hormone deficiency and acromegaly.
-
CLINICAL_TRIALS trial_result · 2009-08-12Clinical Trial Update: Non Interventional Study For Patients Treated With Somavert®
Pfizer conducted a non-interventional study of patients treated with Somavert (pegvisomant) for acromegaly; the study is completed and resul…
-
CLINICAL_TRIALS research · 2009-06-10Clinical Trial Update: Lanreotide Levels in Acromegaly
This clinical trial update covers lanreotide levels in acromegaly; the current trial status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients [Phase 3]
An open-label extension study in acromegaly evaluating the safety and biological activity of C2L-OCT-01 PR in a Phase 3 setting has complete…
-
FDA approval · 2009-03-03FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Octreotide acetate from Hikma Pharmaceuticals USA Inc., updating the regulatory status of the ge…
-
FDA approval · 2009-03-03FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for octreotide acetate submitted by Hikma Pharmaceuticals USA Inc., under the ANDA pathway.
-
CLINICAL_TRIALS trial_result · 2008-10-08Clinical Trial Update: Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients [Phase 3]
Phase 3 trial update on the efficacy and safety of C2L-OCT-01 PR in acromegaly patients; the study has completed.
-
CLINICAL_TRIALS withdrawal · 2008-10-06Clinical Trial Update: Inter-Assay Growth Hormone and IGF-I Variability
This Clinical Trials entry indicates that the inter-assay variability study for growth hormone and IGF-I in acromegaly and growth hormone de…
-
FDA approval · 2008-10-03FDA Approved: SOMAVERT — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for Somavert (pegvisomant) filed by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2008-10-01FDA Approved: BROMOCRIPTINE MESYLATE — Original Application (Padagis US LLC)
FDA approved Padagis US LLC's original generic application for bromocriptine mesylate. This approval provides a generic version of bromocrip…
-
FDA approval · 2008-08-18FDA Approved: SOMAVERT — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for Somavert (pegvisomant) submitted by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2008-07-30FDA Approved: BROMOCRIPTINE MESYLATE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved Zydus Pharmaceuticals USA Inc.'s generic bromocriptine mesylate product under an Original Application (ANDA). Bromocriptine mes…
-
CLINICAL_TRIALS trial_result · 2008-07-29Clinical Trial Update: Long Term Study With B2036-PEG [Phase 3]
Pfizer reports the long-term Phase 3 study of B2036-PEG in acromegaly has completed.
-
CLINICAL_TRIALS trial_result · 2008-06-23Clinical Trial Update: Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
This completed trial compares somatostatin analog therapy versus surgical treatment on glucose metabolism in acromegaly.
-
CLINICAL_TRIALS trial_result · 2008-04-24Clinical Trial Update: Canadian Pegvisomant Compassionate Study In Acromegalic Patients [Phase 4]
Pfizer's pegvisomant compassionate-use Phase 4 study in acromegaly patients has completed in Canada.
-
CLINICAL_TRIALS trial_result · 2008-04-07Clinical Trial Update: Pegvisomant And Sandostatin LAR Combination Study [Phase 4]
Phase 4 study evaluating pegvisomant in combination with Sandostatin LAR for acromegaly has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-07Clinical Trial Update: A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly [Phase 4]
A Phase 4 trial comparing pegvisomant to Sandostatin LAR Depot for efficacy and safety in acromegaly has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: Acute Application of Pegvisomant and Octreotide in Acromegaly [Phase 4]
A Phase 4 clinical trial update examining the acute use of pegvisomant and octreotide in patients with acromegaly.
-
CLINICAL_TRIALS trial_result · 2008-03-25Clinical Trial Update: Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients [Phase 4]
This Phase 4 clinical trial update reports changes in quality of life after addition of weekly 40 mg pegvisomant versus placebo in controlle…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Sandostatin LAR Depot vs. Surgery for Treating Acromegaly [Phase 2]
A Phase 2 trial comparing Sandostatin LAR Depot to surgery for acromegaly has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-03Clinical Trial Update: Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly [Phase 4]
Phase 4 clinical trial update indicates Lanreotide Autogel 120 mg was studied as first-line therapy for acromegaly; the trial status is comp…
-
CLINICAL_TRIALS trial_result · 2008-02-15Clinical Trial Update: Prediction of Tumor Shrinkage in Acromegaly
This clinical trial update reports on a completed study evaluating predictors of tumor shrinkage in acromegaly.
-
CLINICAL_TRIALS trial_result · 2008-02-14Clinical Trial Update: Cardiovascular Outcome After Surgery or Somatostatin Analogues
This clinical trial update reports cardiovascular outcomes in acromegaly patients treated with surgery versus somatostatin analogue therapy,…